Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)

NCT04064411 is registered in ClinicalTrials.gov with Radius Health, Inc. as lead sponsor.

NCT NCT04064411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04064411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
Lead sponsor
Radius Health, Inc.
Phase
Phase 3
Overall status
Completed
Start date
August 5, 2019
Completion date
November 9, 2021
Enrollment
511 (actual)
Sites
97

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal osteoporosis